HCPCS G9412: CIED Infection Requiring Device Removal or Surgical Revision - OpenPayer

Summary & Overview

HCPCS G9412: CIED Infection Requiring Device Removal or Surgical Revision

HCPCS Level II code G9412 denotes care for a patient admitted within 180 days following cardiac implantable electronic device (CIED) implantation, replacement, or revision who develops an infection requiring device removal or surgical revision. The code is relevant nationally as hospitals and surgical teams treat device-related infections that carry significant morbidity, lengthen hospital stays, and increase resource use.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for G9412, typical sites of service, and which payers commonly encounter claims with this code. The publication outlines expected service types tied to the code and highlights associated documentation elements relevant to billing and claim submission.

This summary provides benchmarks and policy-relevant context where available, clarifies clinical circumstances that map to the code, and identifies gaps where data is not provided. The content is intended for billing managers, revenue cycle professionals, and clinical leaders seeking a clear national overview of the purpose and typical use of G9412 in hospital surgical care.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9412HCPCS Level IIcardiac implantable electronic devicedevice infectiondevice removalsurgical revisioninpatienthospital billing

Billing Code Overview

HCPCS Level II code G9412 describes a patient admitted within 180 days who is status post cardiac implantable electronic device (CIED) implantation, replacement, or revision with an infection requiring device removal or surgical revision. This code represents services tied to management of device-related infection after CIED procedures.

Service type: Surgical management and device removal or revision for infected cardiac implantable electronic device
Typical site of service: Inpatient hospital or surgical setting

Clinical & Coding Specifications

Clinical Context

A 68-year-old male with a prior cardiac implantable electronic device (CIED) placed 9 months earlier presents to the emergency department with fever, erythema and purulent drainage at the device pocket site, and positive blood cultures for Staphylococcus aureus. The patient is admitted within 180 days of the most recent CIED implantation, replacement, or revision for management of a device-related infection. The typical clinical workflow includes emergency or inpatient evaluation by cardiology and cardiothoracic surgery, initiation of intravenous antibiotic therapy, diagnostic imaging as needed (chest radiograph, echocardiography to assess for lead-associated endocarditis), consultation for device extraction, removal of the generator and leads in the operating room or hybrid suite, temporary pacing support if indicated, wound debridement, and planning for delayed reimplantation when infection is cleared. Inpatient billing uses HCPCS Level II code G9412 to indicate admission within 180 days status post CIED implantation, replacement, or revision complicated by infection requiring device removal or surgical revision. Typical site of service is the inpatient hospital, often in the operating room, cardiac catheterization lab, or hybrid electrophysiology suite. Common payors for authorization and billing processes include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.

Coding Specifications

Modifier	Description	When to Use
`22`

HCPCS G9316: Patient-Specific Risk Assessment and Communication

HCPCS-G9383-HCV-SCREENING-12-MONTH-REPORTING

HCPCS G9383: HCV Screening Within 12-Month Reporting Period

HCPCS-G8816-STATIN-PRESCRIBED-AT-DISCHARGE

HCPCS G8816: Statin Medication Prescribed at Discharge

HCPCS-G9577-OPIOID-THERAPY-OVER-SIX-WEEKS

HCPCS G9577: Patients Prescribed Opiates Longer Than Six Weeks

HCPCS-G2208-ADJUVANT-CHEMO-HER2-THERAPY-OMISSION

HCPCS G2208: Omission of Adjuvant Chemotherapy plus HER2-Targeted Therapy

HCPCS-G8925-SPIROMETRY-FEV1-60-PERCENT-FEV1-FVC-70-PERCENT-NO-COPD-SYMPTOMS

HCPCS G8925: Spirometry Interpretation — FEV1 ≥60% and FEV1/FVC ≥70%

HCPCS-G9679-ACUTE-PNEUMONIA-TREATMENT-NURSING-FACILITY

HCPCS G9679: Onsite Acute Treatment for Nursing Facility Pneumonia

HCPCS-G8958-VOLUME-MANAGEMENT-ASSESSMENT-NOT-DOCUMENTED

HCPCS G8958: Assessment of Volume Management Adequacy Not Documented

HCPCS-G1014-CLINICAL-DECISION-SUPPORT-SEMANTIC-ANSWERS

HCPCS G1014: Clinical Decision Support Semantic Answers in Medicine

HCPCS-G9912-HBV-ASSESSMENT-BEFORE-ANTI-TNF-THERAPY

HCPCS G9912: Hepatitis B Assessment and Interpretation Before Anti-TNF Therapy

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RP0000X`	Cardiology	Electrophysiologists and cardiologists manage device therapy and infections.
`207LU0401X`	Cardiac Electrophysiology	Specialists who implant and extract CIEDs.
`208000000X`	Cardiothoracic Surgery	Surgeons perform complex extractions, lead revisions, and pocket revisions.
`363A00000X`	General Surgery	May assist with pocket debridement and wound management.
`207Q00000X`	Internal Medicine	Hospitalists manage inpatient medical care and antibiotic therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T82.7XXA`	Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter	Specifies device-related infection requiring device removal or revision.
`T82.89XA`	Other complications of cardiac device, implant and graft, initial encounter	Captures other device complications including pocket infection or erosion leading to removal.
`I33.0`	Acute and subacute infective endocarditis	Relevant when bloodstream infection involves endocardial structures or leads.
`B95.61`	Methicillin susceptible Staphylococcus aureus as the cause of diseases classified elsewhere	Used as an organism code to identify causative pathogen when documented.
`B95.62`	Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere	Used when MRSA is identified as the causative organism.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`33235`	Removal of pacemaker pulse generator only; without replacement	Used when infected generator is explanted and leads are left in place.
`33244`	Removal of pacing leads, with lead(s) extraction, any method; percutaneous	Used for percutaneous lead extraction during infected CIED removal.
`33262`	Removal of implantable cardioverter-defibrillator (ICD) pulse generator only; without replacement	Used when an infected ICD generator is removed without lead extraction.
`33265`	Removal of transvenous pacemaker electrode, complete, with extraction of lead(s)	Used for complete lead extraction when infection involves intravascular leads.
`36415`	Collection of venous blood by venipuncture	Performed for blood cultures and labs prior to and during admission and treatment.
`93740`	Right heart catheterization including measurement(s) of oxygen; cardiac output, when performed	May be used selectively when invasive hemodynamic assessment or lead positioning is needed in complex cases.

OpenPayer